Ugur Sahin
MD, PhD
Co-Founder and CEO
👥Biography 个人简介
Ugur Sahin is the co-founder and CEO of BioNTech, where he pioneered the development of individualized mRNA cancer vaccines. He developed the iNeST (individualized neoantigen specific immunotherapy) platform that analyzes each patient's tumor mutations to design personalized mRNA vaccines. His work on BNT111 melanoma vaccine and broader individualized neoantigen therapy programs has set new standards for personalized oncology. His approach integrates bioinformatics, mRNA manufacturing, and clinical trial design.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-03-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Ugur Sahin 的研究动态
Follow Ugur Sahin's research updates
留下邮箱，当我们发布与 Ugur Sahin（BioNTech SE）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment